Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-28

Clinical Trial Update: Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis [Phase 4]

View source ↗

Summary

A Phase 4 study reports the pharmacokinetics of ertapenem in patients undergoing continuous venovenous hemodialysis for acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Invanz (ertapenem)

Snippet

Sponsor: University of Michigan | Conditions: Acute Kidney Failure | Phase 4 | Status: COMPLETED | Results posted: 2012-09-28